People: Biogen Inc (BIIB.OQ)
Dr. Paul McKenzie, Ph.D. is Executive Vice President, Pharmaceutical Operations and Technology of Biogen Inc. Prior to that, from February 2016 to June 2016, he served as our Senior Vice President for Global Biologics Manufacturing & Technical Operations. Prior to joining Biogen, beginning in 2008, Dr. McKenzie held a number of positions of increasing responsibility at J&J, including Vice President of R&D for J&J’s Ethicon business and Global Head of Pharmaceutical Manufacturing and Technical Operations, where he led the manufacturing and technical operations team responsible for internal and external manufacturing of Janssen’s pharmaceutical portfolio. He also ran global Development for Janssen R&D, helping to manage pipeline activities from discovery through clinical development and commercialization. Prior to J&J, Dr. McKenzie also held various R&D and manufacturing positions at BMS and Merck, both of which are pharmaceutical companies.
|Total Annual Compensation, USD||1,397,080|
|Restricted Stock Award, USD||3,514,450|
|Long-Term Incentive Plans, USD||--|
|All Other, USD||103,725|
|Fiscal Year Total, USD||5,015,260|